|
Market Closed -
Nasdaq
16:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 1.110 USD | -5.13% |
|
-1.77% | -52.36% |
| 10-26 | Spero Therapeutics, Inc. Announces Executive Changes | CI |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -5.13% | -1.77% | -7.50% | -6.72% | -52.36% | -52.36% | +8.82% | -93.68% | - | 64.64M | |
| +0.34% | +1.12% | -11.06% | +12.96% | +57.65% | +34.75% | +61.06% | +3.54% | - | 64.38B | |
| +0.98% | +2.68% | -5.19% | +3.71% | +12.22% | +12.25% | +82.98% | +210.70% | +5,517.32% | 56.16B | |
| +1.75% | +2.01% | +9.73% | +11.48% | +19.15% | +13.30% | +103.69% | -14.63% | +239.95% | 54.16B | |
| -1.43% | -1.17% | +2.26% | +11.11% | +22.03% | +26.27% | +52.86% | +5.22% | +283.25% | 45.33B | |
| -0.48% | -2.80% | +1.72% | +13.55% | +22.30% | +18.01% | +117.99% | +3.87% | +1,010.13% | 42.25B | |
| +0.82% | +1.37% | -6.95% | +5.17% | +138.88% | +227.94% | +922.41% | +546.52% | - | 40.78B | |
| -2.07% | +42.73% | +63.49% | +102.89% | +86.88% | +103.77% | +88.74% | +31.35% | +235.22% | 33.8B | |
| -0.26% | -2.57% | +5.81% | +5.17% | +9.81% | +12.55% | +45.18% | +14.84% | +157.79% | 32.25B | |
| -1.64% | -3.32% | -21.00% | +17.14% | +40.84% | +21.05% | -12.32% | -60.29% | - | 23.57B | |
| +1.30% | -0.60% | -9.58% | -4.11% | -6.38% | -13.76% | -2.27% | -68.02% | - | 22.39B | |
| +15.06% | +17.39% | -3.49% | +8.21% | -35.88% | -33.16% | +367.29% | +270.12% | +724.15% | 24.37B | |
| -2.18% | +3.61% | +8.91% | +15.84% | +20.64% | +15.91% | +170.72% | +199.08% | +2,245.31% | 18.95B | |
| +0.57% | +10.73% | +27.08% | +60.18% | +88.54% | +108.77% | +117.92% | -16.18% | +394.87% | 17.95B | |
| +0.97% | +4.59% | +14.28% | +26.86% | +39.55% | +43.70% | +88.16% | -14.58% | +112.26% | 16.88B | |
| -0.12% | +1.36% | +12.87% | +19.65% | +51.04% | +67.89% | +227.72% | +207.76% | +508.46% | 16.4B | |
| +1.38% | +4.12% | +10.93% | +0.38% | - | - | - | - | - | 16.62B | |
| +0.62% | +16.21% | +26.49% | +20.93% | +18.25% | +29.85% | -8.43% | -24.86% | +168.28% | 16.14B | |
| +3.33% | +6.90% | +3.77% | +14.81% | +192.66% | +177.32% | +360.46% | +1,470.41% | +825.12% | 15.77B | |
| +1.61% | +21.99% | -5.74% | +87.34% | +31.82% | -12.38% | - | - | - | 14.05B | |
| Average | +0.77% | +6.18% | +5.84% | +21.33% | +39.88% | +42.19% | +155.17% | +148.40% | +955.55% | 28.61B | |
| Weighted average by Cap. | +0.85% | +5.08% | +4.63% | +19.34% | +42.29% | +45.70% | +163.21% | +126.58% | +1,241.41% |
- Stock Market
- Stocks
- SPRO Stock
- Sector Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
